小细胞肺癌NCCN指南最新版.docx

小细胞肺癌NCCN指南最新版.docx

《小细胞肺癌NCCN指南最新版.docx》由会员分享，可在线阅读，更多相关《小细胞肺癌NCCN指南最新版.docx（27页珍藏版）》请在冰豆网上搜索。

小细胞肺癌NCCN指南最新版

PrintedbyqingBuon8/16/20122:

02:

09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancer157.MaranzanoE,TrippaF,CasaleM,etal.8Gysingle-doseradiotherapyiseffectiveinmetastaticspinalcordcompression:

resultsofaphaseIIIrandomizedmulticentreItaliantrial.RadiotherOncol2009;93:

174-179.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/19520448.158.LutzS,BerkL,ChangE,etal.Palliativeradiotherapyforbonemetastases:

anASTROevidence-basedguideline.IntJRadiatOncolBiolPhys2011;79:

965-976.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21277118.159.FerrellB,KoczywasM,GrannisF,HarringtonA.Palliativecareinlungcancer.SurgClinNorthAm2011;91:

403-417,ix.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21419260.160.TsaoMN,LloydN,WongRK,etal.Wholebrainradiotherapyforthetreatmentofnewlydiagnosedmultiplebrainmetastases.CochraneDatabaseSystRev2012;4:

CD003869.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/22513917.161.SchneiderBJ,SaxenaA,DowneyRJ.Surgeryforearly-stagesmallcelllungcancer.JNatlComprCancNetw2011;9:

1132-1139.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21975913.162.LadT,PiantadosiS,ThomasP,etal.Aprospectiverandomizedtrialtodeterminethebenefitofsurgicalresectionofresidualdiseasefollowingresponseofsmallcelllungcancertocombinationchemotherapy.Chest1994;106:

320S-323S.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/7988254.163.RostadH,NaalsundA,JacobsenR,etal.SmallcelllungcancerinNorway.Shouldmorepatientshavebeenofferedsurgicaltherapy?

EurJCardiothoracSurg2004;26:

782-786.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15450573.164.InoueM,MiyoshiS,YasumitsuT,etal.SurgicalresultsforsmallcelllungcancerbasedonthenewTNMstagingsystem.ThoracicSurgeryStudyGroupofOsakaUniversity,Osaka,Japan.AnnThoracSurg2000;70:

1615-1619.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/11093496.NCCNGuidelinesIndexSCLCTableofContentsDiscussion165.BrockMV,HookerCM,SyphardJE,etal.Surgicalresectionoflimiteddiseasesmallcelllungcancerintheneweraofplatinumchemotherapy:

Itstimehascome.JThoracCardiovascSurg2005;129:

64-72.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15632826.166.LimE,BelcherE,YapYK,etal.Theroleofsurgeryinthetreatmentoflimiteddiseasesmallcelllungcancer:

timetoreevaluate.JThoracOncol2008;3:

1267-1271.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/18978561.167.ShieldsTW,HigginsGA,Jr.,MatthewsMJ,KeehnRJ.Surgicalresectioninthemanagementofsmallcellcarcinomaofthelung.JThoracCardiovascSurg1982;84:

481-488.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/6289013.168.SchreiberD,RineerJ,WeedonJ,etal.Survivaloutcomeswiththeuseofsurgeryinlimited-stagesmallcelllungcancer:

shoulditsrolebere-evaluated?

Cancer2010;116:

1350-1357.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/20082453.169.InoueM,NakagawaK,FujiwaraK,etal.Resultsofpreoperativemediastinoscopyforsmallcelllungcancer.AnnThoracSurg2000;70:

1620-1623.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/11093497.170.ShepherdFA,EvansWK,FeldR,etal.Adjuvantchemotherapyfollowingsurgicalresectionforsmall-cellcarcinomaofthelung.JClinOncol1988;6:

832-838.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/2835443.171.TsuchiyaR,SuzukiK,IchinoseY,etal.PhaseIItrialofpostoperativeadjuvantcisplatinandetoposideinpatientswithcompletelyresectedstageI-IIIasmallcelllungcancer:

theJapanClinicalOncologyLungCancerStudyGroupTrial（JCOG9101.JREF-12Version2.2013,07/06/12©NationalComprehensiveCancerNetwork,Inc.2012,Allrightsreserved.TheNCCNGuidelines®andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®.

PrintedbyqingBuon8/16/20122:

02:

09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancerThoracCardiovascSurg2005;129:

977-983.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15867769.172.JohnsonBE,LinnoilaRI,WilliamsJP,etal.Riskofsecondaerodigestivecancersincreasesinpatientswhosurvivefreeofsmallcelllungcancerformorethan2years.JClinOncol1995;13:

101-111.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/7799009.173.JohnsonBE.Secondlungcancersinpatientsaftertreatmentforaninitiallungcancer.JNatlCancerInst1998;90:

1335-1345.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/9747865.174.RichardsonGE,TuckerMA,VenzonDJ,etal.Smokingcessationaftersuccessfultreatmentofsmall-celllungcancerisassociatedwithfewersmoking-relatedsecondprimarycancers.AnnInternMed1993;119:

383-390.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/8393311.175.KawaharaM,UshijimaS,KamimoriT,etal.Secondprimarytumoursinmorethan2-yeardisease-freesurvivorsofsmall-celllungcancerinJapan:

theroleofsmokingcessation.BrJCancer1998;78:

409-412.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/9703291.176.ParsonsA,DaleyA,BeghR,AveyardP.Influenceofsmokingcessationafterdiagnosisofearlystagelungcanceronprognosis:

systematicreviewofobservationalstudieswithmeta-analysis.BMJ2010;340:

b5569.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/20093278.177.TravisW,BrambillaE,Müller-HermelinkH.WorldHealthOrganizationClassificationoftumours:

Pathologyandgeneticsoftumoursofthelung,pleura,thymusandheart.Lyon,France:

IARCPress;2004.178.BajettaE,CatenaL,ProcopioG,etal.IsthenewWHOclassificationofneuroendocrinetumoursusefulforselectinganNCCNGuidelinesIndexSCLCTableofContentsDiscussionappropriatetreatment?

AnnOncol2005;16:

1374-1380.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15939719.179.KalemkerianGP.Pulmonaryneuroendocrinecarcinomas:

progressandpitfalls.JNatlComprCancNetw2011;9:

1081-1082.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21975910.180.VarlottoJM,Medford-DavisLN,RechtA,etal.Shouldlargecellneuroendocrinelungcarcinomabeclassifiedandtreatedasasmallcelllungcancerorwithotherlargecellcarcinomas?

JThoracOncol2011;6:

1050-1058.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21566535.181.TravisWD,GirouxDJ,ChanskyK,etal.TheIASLCLungCancerStagingProject:

proposalsfortheinclusionofbroncho-pulmonarycarcinoidtumorsintheforthcoming（seventheditionoftheTNMClassificationforLungCancer.JThoracOncol2008;3:

1213-1223.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/18978555.182.PuscedduS,CatenaL,ValenteM,etal.Long-termfollowupofpatientsaffectedbypulmonarycarcinoidattheIstitutoNazionaleTumoriofMilan:

aretrospectiveanalysis.JThoracDis2010;2:

16-20.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/22263011.183.KyrissT,MaierS,VeitS,etal.Carcinoidlungtumors:

long-termresultsfrom111resections.ThoracSurgSci2006;3:

Doc03.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/21289951.184.ReaF,RizzardiG,ZuinA,etal.Outcomeandsurgicalstrategyinbronchialcarcinoidtumors:

singleinstitutionexperiencewith252patients.EurJCardiothoracSurg2007;31:

186-191.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/17140801.185.DetterbeckFC.Managementofcarcinoidtumors.AnnThoracSurg2010;89:

998-1005.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/20172187.Version2.2013,07/06/12©NationalComprehensiveCancerNetwork,Inc.2012,Allrightsreserved.TheNCCNGuidelines®andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN®.REF-13

PrintedbyqingBuon8/16/20122:

02:

09AM.Forpersonaluseonly.Notapprovedfordistribution.Copyright©2012NationalComprehensiveCancerNetwork,Inc.,AllRightsReserved.NCCNGuidelinesVersion2.2013SmallCellLungCancer186.CardilloG,SeraF,DiMartinoM,etal.Bronchialcarcinoidtumors:

nodalstatusandlong-termsurvivalafterresection.AnnThoracSurg2004;77:

1781-1785.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15111186.187.WirthLJ,CarterMR,JannePA,JohnsonBE.Outcomeofpatientswithpulmonarycarcinoidtumorsreceivingchemotherapyorchemoradiotherapy.LungCancer2004;44:

213-220.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/15084386.188.YaoJC,PhanAT,ChangDZ,etal.EfficacyofRAD001（everolimusandoctreotideLARinadvancedlow-tointermediategradeneuroendocrinetumors:

resultsofaphaseIIstudy.JClinOncol2008;26:

4311-4318.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/18779618.189.MoertelCG,KvolsLK,O'ConnellMJ,RubinJ.Treatmentofneuroendocrinecarcinomaswithcombinedetoposideandcisplatin.Evidenceofmajortherapeuticactivityintheanaplasticvariantsoftheseneoplasms.Cancer1991;68:

227-232.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/1712661.190.EkebladS,SundinA,JansonET,etal.Temozolomideasmonotherapyiseffectiveintreatmentofadvancedmalignantneuroendocrinetumors.ClinCancerRes2007;13:

2986-2991.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/17505000.191.KulkeMH,HornickJL,FrauenhofferC,etal.O6-methylguanineDNAmethyltransferasedeficiencyandresponsetotemozolomidebasedtherapyinpatientswithneuroendocrinetumors.ClinCancerRes2009;15:

338-345.Availableat:

http:

//www.ncbi.nlm.nih.gov/pubmed/19118063.192.KulkeMH,LenzHJ,MeropolNJ,etal.Activityof